MedPath

Evaluation of role of oral supplementation of Vitamin B12 and folate in Open Angle Glaucoma

Not yet recruiting
Conditions
Open-angle glaucoma,
Registration Number
CTRI/2024/08/072110
Lead Sponsor
Post Graduate Institute of Medicine Education and Research
Brief Summary

This study in a interventional randomized controlled prospective trial which aims to evaluate the neuroprotective role of Vitamin B 12 and Folate in glaucoma progression.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
144
Inclusion Criteria

Patients diagnosed with Primary open angle glaucoma, normal tension glaucoma and pseudoexfolaituve glaucoma on medical management and give their consent for enrollment in trial.

Exclusion Criteria

Patient with age less than 40 years and more than 70 years with preexisting colour vision deficiency and best corrected visual acuity of less than 20/40 due to reasons other than glaucoma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome will be to analyze the progression of glaucoma after oral supplementation of Vitamin B 12 and folate.This will be done at the presentation and after 6 months of follow up.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome will be to analyze the correlation between serum levels of Vitamin B 12 ad folate in glaucoma progression.This will be done at the presentation & after 6 months of follow up.

Trial Locations

Locations (1)

Post Graduate Institute of Medicine Education and Research

🇮🇳

Chandigarh, CHANDIGARH, India

Post Graduate Institute of Medicine Education and Research
🇮🇳Chandigarh, CHANDIGARH, India
DrSrishti Raj
Principal investigator
09463503967
srishtipgi@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.